Sterically Controlled Cyclobutane-Dioxetane Ultrabright Afterglow Nanosystem for Cyclic Therapy of Choroidal Neovascularization in Mice
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c05187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Jiawei Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials & Collaborative Innovation Center of Suzhou Nano Science and Technology (NANO-CIC), Soochow University,…. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Cyclobutanes, Heterocyclic Compounds, Photosensitizing Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China, China Postdoctoral Science Foundation, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Afterglow occurring after light excitation ceases offers a safer light source to the laser-activated verteporfin therapy approved by the FDA for choroidal neovascularization (CNV). However, conventional afterglow molecules, especially adamantane-dioxetanes with high steric hindrance, exhibit limited chemiexcitation, restricting electron transfer and diminishing therapeutic effects. Here, we constructed ultrabright afterglow nanosystems by integrating low-hindrance cyclobutane moieties into the dioxetane framework. Among these cyclobutane substituents, the benzyl oxocyclobutane-dioxetane is the brightest afterglow molecule due to its lowest hindrance, showing 35.7 times faster relative chemiexcitation rate and 59 times higher afterglow intensity than adamantane-dioxetane, alongside a three-order-of-magnitude increase in total afterglow emission. Consequently, at the equivalent concentration, the benzyl oxocyclobutane-dioxetane-based nanosystem produces nearly five times more singlet oxygen than free verteporfin. In a CNV mouse model, cyclic treatment with our nanosystem reduced lesion areas by 64.9%, outperforming the 39.3% reduction achieved by free verteporfin counterpart. By eliminating the need for laser activation, this strategy minimizes ocular damage, providing a safe and effective treatment for CNV and other retinal disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Functional Nano & Soft Materials & Collaborative Innovation Center of Suzhou Nano Science and Technology (NANO-CIC), Soochow University, Suzhou 215123, China.
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, P. R. China.
- Macao Translational Medicine Center, Macau University of Science and Technology, Taipa, Macau 999078, SAR, China.
- Macao Institute of Materials Science and Engineering, Macau University of Science and Technology, Taipa, Macau 999078, SAR, China.
ORCID-Profile: Yufan Ling, Houyu Wang, Yao He
Förderung
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Suzhou Applied Basic Research Science and Technology Innovation Program
Zitieren
APA
Zhang, J., Shi, H., Qin, X., Wang, P., Ling, Y., Jin, X., Cui, M., Song, B., Wang, H., & He, Y. (2025). Sterically Controlled Cyclobutane-Dioxetane Ultrabright Afterglow Nanosystem for Cyclic Therapy of Choroidal Neovascularization in Mice. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c05187
Vancouver
Zhang J, Shi H, Qin X, Wang P, Ling Y, Jin X, et al. Sterically Controlled Cyclobutane-Dioxetane Ultrabright Afterglow Nanosystem for Cyclic Therapy of Choroidal Neovascularization in Mice. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c05187
BibTeX
@article{Zhang2025,
author = {Zhang, Jiawei and Shi, Haoliang and Qin, Xuan and Wang, Pengcheng and Ling, Yufan and Jin, Xiangbowen and Cui, Mingyue and Song, Bin and Wang, Houyu and He, Yao},
title = {Sterically Controlled Cyclobutane-Dioxetane Ultrabright Afterglow Nanosystem for Cyclic Therapy of Choroidal Neovascularization in Mice},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c05187}
}
EUVIMED